Literature DB >> 15999539

Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity.

Tadashi Matsumura1, Nagio Takigawa, Katsuyuki Kiura, Takuo Shibayama, Masakazu Chikamori, Masahiro Tabata, Hiroshi Ueoka, Mitsune Tanimoto.   

Abstract

To elucidate the sensitivity of adenocarcinoma of the lung to cisplatin and irinotecan, intracellular glutathione (GSH) and glutathione S-transferase (GST)-pi concentrations and topoisomerase (topo) I activity were investigated using six adenocarcinoma cell lines. The antiproliferative activity was determined by MTT assay in terms of inhibition concentration (IC50) values. The IC50 values to cisplatin were not correlated with the amounts of intracellular GSH or GST-pi, but with intracellular accumulation of platinum (r = -0.91, p = 0.013). IC50 values to SN-38 were correlated with topo I activity determined by relaxation assay of pBR322 (r = -0.83, p = 0.040). These results suggest that platinum accumulation and topo I activity have definite impacts on the sensitivity of lung adenocarcinoma to cisplatin and irinotecan, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999539

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

1.  Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.

Authors:  Eric S Kim; XiMing Tang; Derick R Peterson; Deepak Kilari; Chi-Wan Chow; Junya Fujimoto; Neda Kalhor; Stephen G Swisher; David J Stewart; Ignacio I Wistuba; Zahid H Siddik
Journal:  Lung Cancer       Date:  2014-04-22       Impact factor: 5.705

2.  Tissue platinum concentration and tumor response in non-small-cell lung cancer.

Authors:  Eric S Kim; J Jack Lee; Guangan He; Chi-Wan Chow; Junya Fujimoto; Neda Kalhor; Stephen G Swisher; Ignacio I Wistuba; David J Stewart; Zahid H Siddik
Journal:  J Clin Oncol       Date:  2012-08-13       Impact factor: 44.544

3.  Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry.

Authors:  Joanna Will; William S Sheldrick; Dirk Wolters
Journal:  J Biol Inorg Chem       Date:  2007-12-22       Impact factor: 3.358

Review 4.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

5.  Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs.

Authors:  Pushkar Kulkarni; Marina Rajadurai; Aarti Sevilimedu; Surendar Basaveni; Swapna Yellanki; Raghavender Medishetti; Uday Saxena
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.